Can resistance against quorum-sensing interference be selected?
- PMID:26023871
- PMCID: PMC4681860
- DOI: 10.1038/ismej.2015.84
Can resistance against quorum-sensing interference be selected?
Abstract
Quorum-sensing (QS) interference is a novel therapy to fight bacterial infections that, unlike conventional antibiotic treatments, is focused on reducing the damage caused by pathogens (virulence) rather than focused on inhibiting their growth. Given this ideal, it was predicted that this approach will be impervious to or at least much less prone to resistance in bacterial populations. However, recently, resistance mechanisms against well-characterized quorum quenchers (QQs) have been found in the laboratory as well as in clinical strains, demonstrating that the rise of resistance against these kinds of compounds is possible. Nevertheless, it has been argued that even if resistance mechanisms against QS interference exist, this fact does not guarantee that resistance will spread. In the present work, we discuss recent insights derived from the latest experiments to address this question. In addition, we explain how environmental conditions like the stress produced by the host immune system may influence the selection of resistance and eventually lead to the selection of QS interference-resistant bacteria in a clinical setting.
Figures

Similar articles
- Bacterial quorum sensing inhibitors: attractive alternatives for control of infectious pathogens showing multiple drug resistance.Bhardwaj AK, Vinothkumar K, Rajpara N.Bhardwaj AK, et al.Recent Pat Antiinfect Drug Discov. 2013 Apr;8(1):68-83. doi: 10.2174/1574891x11308010012.Recent Pat Antiinfect Drug Discov. 2013.PMID:23394143Review.
- Quorum-Sensing Systems as Targets for Antivirulence Therapy.Defoirdt T.Defoirdt T.Trends Microbiol. 2018 Apr;26(4):313-328. doi: 10.1016/j.tim.2017.10.005. Epub 2017 Nov 10.Trends Microbiol. 2018.PMID:29132819Review.
- Quorum sensing pathways in Gram-positive and -negative bacteria: potential of their interruption in abating drug resistance.Haque S, Yadav DK, Bisht SC, Yadav N, Singh V, Dubey KK, Jawed A, Wahid M, Dar SA.Haque S, et al.J Chemother. 2019 Jul;31(4):161-187. doi: 10.1080/1120009X.2019.1599175. Epub 2019 Apr 22.J Chemother. 2019.PMID:31007147Review.
- Quenching the quorum sensing system: potential antibacterial drug targets.Kalia VC, Purohit HJ.Kalia VC, et al.Crit Rev Microbiol. 2011 May;37(2):121-40. doi: 10.3109/1040841X.2010.532479. Epub 2011 Jan 27.Crit Rev Microbiol. 2011.PMID:21271798Review.
- [Quorum sensing and quorum quenching: how to disrupt bacterial communication to inhibit virulence?].Mion S, Rémy B, Plener L, Chabrière É, Daudé D.Mion S, et al.Med Sci (Paris). 2019 Jan;35(1):31-38. doi: 10.1051/medsci/2018310. Epub 2019 Jan 23.Med Sci (Paris). 2019.PMID:30672458Review.French.
Cited by
- The New Antibacterial Properties of the Plants:Quo vadis Studies of Anti-virulence Phytochemicals?Díaz-Nuñez JL, García-Contreras R, Castillo-Juárez I.Díaz-Nuñez JL, et al.Front Microbiol. 2021 May 7;12:667126. doi: 10.3389/fmicb.2021.667126. eCollection 2021.Front Microbiol. 2021.PMID:34025622Free PMC article.Review.
- Appropriate Targets for Antibacterial Drugs.Silver LL.Silver LL.Cold Spring Harb Perspect Med. 2016 Dec 1;6(12):a030239. doi: 10.1101/cshperspect.a030239.Cold Spring Harb Perspect Med. 2016.PMID:27599531Free PMC article.Review.
- Effects of Rhapontigenin as a Novel Quorum-Sensing Inhibitor on Exoenzymes and Biofilm Formation ofPectobacterium carotovorum subsp.carotovorum and Its Application in Vegetables.Li B, Huang J, Yi Y, Liu S, Liu R, Xiao Z, Li C.Li B, et al.Molecules. 2022 Dec 14;27(24):8878. doi: 10.3390/molecules27248878.Molecules. 2022.PMID:36558013Free PMC article.
- "It Is Not Necessary to Kill Them in Order to Make Them Relatively Harmless": Molecular Diplomacy in the Pathogen-Host Interaction.Alverdy JC.Alverdy JC.Surg Infect (Larchmt). 2023 Feb;24(1):1-3. doi: 10.1089/sur.2022.345. Epub 2022 Dec 15.Surg Infect (Larchmt). 2023.PMID:36521176Free PMC article.No abstract available.
- Activity and Impact on Resistance Development of Two Antivirulence Fluoropyrimidine Drugs inPseudomonas aeruginosa.Imperi F, Fiscarelli EV, Visaggio D, Leoni L, Visca P.Imperi F, et al.Front Cell Infect Microbiol. 2019 Mar 11;9:49. doi: 10.3389/fcimb.2019.00049. eCollection 2019.Front Cell Infect Microbiol. 2019.PMID:30915278Free PMC article.
References
- Allen RC, Popat R, Diggle SP, Brown SP. (2014). Targeting virulence: can we make evolution-proof drugs? Nat Rev Microbiol 12: 300–308. - PubMed
- Bjarnsholt T, Tolker-Nielsen T, Hoiby N, Givskov M. (2010). Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control. Expert Rev Mol Med 12: e11. - PubMed
- Castric PA. (1975). Hydrogen cyanide, a secondary metabolite of Pseudomonas aeruginosa. Can J Microbiol 21: 613–618. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical